Available Until 12/22/2023

Refocusing on Medication Safety: Best Practices for Injection Safety

NOTE: If you attended this live CE activity AND received CE credit (i.e. a Pharmacist or Pharmacy Technician CE statement of credit with ACPE UAN 0221-9999-21-286-L05-P/T), you are not allowed to also receive credit for this home-study on-demand web activity.

Activity Description

We learned a lot navigating our way through the global COVID-19 pandemic and as we define what will become the new normal it is imperative that medication safety efforts remain in focus. Healthcare practitioners have steered through disruptions in supplies, medications, personal protective equipment, and more, and continue to cope with staffing challenges and other stressors while striving to provide optimal patient care. Additionally, more than 90% of hospitalized patients receive some form of intravenous (IV) therapy, either by infusion or IV push administration. IV medications are known to be clinically advantageous due to their immediate therapeutic effect and ability to support plasma drug levels, and patients being treated for COVID-19 often require multiple high-alert medications. Unfortunately, these practices are not without risk.

With harmful outcomes at stake, ISMP believes it is essential to provide healthcare practitioners with relevant information to assist them in identifying and managing the risks.

This webinar will focus on the challenges of the global COVID-19 pandemic, how practitioners can prevent medication errors despite this disruption, how to refocus on best practices related to IV push medications in adults, and how these strategies can have additional workflow benefits.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Identify how stressors, such as the COVID-19 pandemic, challenge medication safety efforts.
  • Considering pandemic-related disruptions, list strategies to prevent medication errors, including the use of ready-to-administer preparations.
  • Describe three best practices for the use of IV push medications.
  • Explain how best practices for IV push medications can provide additional workflow benefits.


Christina Michalek, BSc Pharm, RPh, FASHP, Medication Safety Specialist, ISMP
Michelle Mandrack, MSN, RN, Director of Consulting Services, ISMP


It is the policy of ProCE, LLC to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed during their presentation. Christina Michalek and Michelle Mandrack do not have any relevant commercial and/or financial relationships to disclose.

CE Accreditation

Release Date: December 22, 2021
Expiration Date: December 22, 2023

Pharmacists and Pharmacy Technicians

This CE activity is jointly provided by ProCE, LLC and the Institute for Safe Medication Practices (ISMP). ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-21-286-H05-P/T has been assigned to this knowledge-based home-study CE activity. This activity is approved for 1.0 contact hour (0.1 CEU) in states that recognize ACPE providers. This CE activity is provided at no cost to participants. Statements of completion will be issued online at www.ProCE.com upon completion of the evaluation and post-test with a score of 70% or higher. Proof of completion will be posted in NABP CPE Monitor profiles. No partial credit will be given.


This CE activity is supported by an educational grant from Fresenius Kabi.


The material presented in this CE activity does not reflect the views of ProCE, LLC or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.